Derma Radia Tablet (15'S)

Manufacturer: Veritaz Healthcare Ltd

Salt Composition : Tranexamic Acid

Prescription
Prescription Required: Consult the Doctor & Get Your ePrescription

₹299.00

Strip of 15 Tablet

(Inclusive of all taxes)


Derma Radia Tablet is an anti-fibrinolytic. It works by preventing the breakdown of clots which leads to the stoppage of bleeding. This medicine must be taken in the dose and duration as advised by the doctor. You should not take it if you have any known allergy to this medicine.



Basic Information

Mechanism Of Action

Tranexamic acid is a synthetic derivative of the amino acid lysine and binds the 5 lysine binding sites on plasminogen. This inhibits plasmin formation and displaces plasminogen from the fibrin surface. It may also directly inhibit plasmin and partially inhibit fibrinogenolysis at higher concentrations

Pharmacokinets

Tranexamic acid 1 g was given intravenously to three healthy volunteers. Plasma concentrations decayed in three monoexponential phases. Most elimination took place during the first eight hours, giving an apparent elimination half-life of approximately two hours. Plasma clearance ranged between 110-116 ml/min.

Side Effects

Musculoskeletal (bone, muscle or joint) pain

Joint pain

Headache

Back pain

Vomiting

Nausea

Abdominal pain

Fatigue

Diarrhea

Hypotension (low blood pressure)

Sinus disorder

Nasal discomfort

Muscle cramp

Migraine

Anemia (low number of red blood cells)

Allergic dermatitis

Lightheadedness

Thromboembolism


Contra Indications

increased risk of blood clotting.

fluid accumulation in the brain.

a clot in the small veins that carry blood to or from the retina of the eye.

a heart attack.

acute blood clot in a blood vessel supplying the lungs.

heart valve disease

Pregnancy Related Information

Derma Radia Tablet is generally considered safe to use during pregnancy. Animal studies have shown low or no adverse effects to the developing baby; however, there are limited human studies.


Product And Alcohol Interaction

Derma Radia Tablet may cause excessive drowsiness with alcohol.


Breast Feeding Related Information

Derma Radia Tablet is probably safe to use during breastfeeding. Limited human data suggests that the drug does not represent any significant risk to the baby.


Indications

Menorrhagia. Indicated for the treatment of cyclic heavy menstrual bleeding. ...

Hereditary Angioedema (Off-label) ...

Cone Biopsy (Off-label) ...

Epistaxis (Off-label) ...

Hyphema (Off-label) ...

Hereditary Angioedema (Off-label) ...

Administration

Interactions

Some products that may interact with this drug include: "blood thinners" (anticoagulants such as warfarin, heparin), drugs that prevent bleeding (including factor IX complex, anti-inhibitor coagulant concentrates), estrogens, hormonal birth control (such as pills, patch, ring), tibolone, tretinoin

Typical Dosage

Do not chew, crush or break it. Derma Radia Tablet is to be taken with food.


Storage Requirements

Store below 30°C


Effects Of Missed Dosage

If you miss a dose of Derma Radia Tablet, skip it and continue with your normal schedule. Do not double the dose.


Effects Of Overdose

Consult a doctor before taking any medicines.


Expert Advice

Derma Radia Tablet helps prevent or reduce heavy bleeding post surgery and in conditions such as heavy periods, dysfunctional uterine bleeding, and nosebleeds.

Your doctor will prescribe the lowest effective dose for the shortest possible time necessary to relieve your symptoms.

If taking for heavy periods, take it on the first day as taking it before or after will not have any benefit.

Your doctor may monitor your vision regularly while you are taking this medicine.

Inform your doctor if you have a history of kidney or liver disease.

Inform your doctor if there is no improvement in your bleeding after using this medicine for three consecutive periods.

How To Use

Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Derma Radia Tablet is to be taken with food.


FAQs

Q. Can Derma Radia Tablet cause pulmonary embolism?

Derma Radia Tablet promotes blood clotting and can rarely cause blood clot to travel to the lungs (pulmonary embolism) which can turn fatal sometimes. Pulmonary embolism is not a common side effect in patients taking Derma Radia Tablet but can occur in overdosing, patients with long bedrest or prone individuals. Evidence suggests that the increased risk of clot can be due to some other additional risk factors as well.

Q. Can you take Derma Radia Tablet on an empty stomach?

Derma Radia Tablet can be taken with or without food with a glass of water. The medicine should be swallowed as a whole and should not be crushed or chewed.

Q. Can I take Derma Radia Tablet for more than 5 days?

The dose and duration of this medicine is decided by the type of disease for which it is prescribed. For heavy bleeding during monthly menstruation, it is usually taken for up to 5 days. For other conditions it can be prescribed for less than 5 days and even more that 5 days which is decided by the prescribing physician.

Q. Does Derma Radia Tablet affect fertility?

No, Derma Radia Tablet does not affect fertility. It is taken for heavy menstrual bleeding and evidence suggests no interference of this medicine with ovulation (release of eggs from the ovaries). Therefore, this medicine is not a type of contraceptive medicine and it will not affect your chances of becoming pregnant.

Q. Can Derma Radia Tablet be taken for nose bleeding?

Yes, Derma Radia Tablet can be used for nose bleeding. It helps to clot the blood and prevent bleeding. If the bleeding is frequently observed then the medicine can be even taken for a week.

Q. Can Derma Radia Tablet cause pulmonary embolism?

Derma Radia Tablet promotes blood clotting and can rarely cause blood clot to travel to the lungs (pulmonary embolism) which can turn fatal sometimes. Pulmonary embolism is not a common side effect in patients taking Derma Radia Tablet but can occur in overdosing, patients with long bedrest or prone individuals. Evidence suggests that the increased risk of clot can be due to some other additional risk factors as well.